Biodegradable microspheres for vitreoretinal drug delivery.
暂无分享,去创建一个
[1] Y. Ogura,et al. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. , 1995, Survey of ophthalmology.
[2] P. A. Pearson,et al. Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. , 2000, Retina.
[3] V. Shah,et al. Statistical Assessment of Mean Differences between Two Dissolution Data Sets* , 1996 .
[4] J P Benoit,et al. Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure. , 1996, Journal of microencapsulation.
[5] P. Giunchedi,et al. Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation , 1997 .
[6] S. Whitcup,et al. New developments in sustained release drug delivery for the treatment of intraocular disease , 1999, The British journal of ophthalmology.
[7] D. D’Amico,et al. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. , 1992, Archives of ophthalmology.
[8] G E Visscher,et al. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.
[9] C. Doyle. Advances in biomaterials: Lee SM editor 1987 Volume 1. Lancaster, PA: Technomics Inc. 286pp. $65 , 1987 .
[10] R. Jalil,et al. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.
[11] Y. Ikada,et al. Lactic acid oligomer microspheres containing hydrophilic drugs. , 1990, Journal of pharmaceutical sciences.
[12] Y. Ikada,et al. Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres. , 1994, Current eye research.
[13] M. Refojo,et al. Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres. , 1995, Current eye research.
[14] Sumie Yoshioka,et al. Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate , 1991 .
[15] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.
[16] J. Bartlett,et al. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. , 1989, Archives of ophthalmology.
[17] I. Grierson,et al. Biomaterials used in the posterior segment of the eye. , 2000, Biomaterials.
[18] P. Sansdrap,et al. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres. , 1998, Journal of microencapsulation.
[19] Andreas Zimmer,et al. Microspheres and nanoparticles used in ocular delivery systems , 1995 .
[20] Y. Ikada,et al. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.
[21] Suming Li,et al. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. , 1999 .
[22] Y. Ikada,et al. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. , 1991, Investigative ophthalmology & visual science.
[23] M. Refojo,et al. VITREOUS SUBSTITUTE: Experimental Studies and Review , 1984, Retina.
[24] Suming Li,et al. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.
[25] Y. Ikada,et al. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. , 1999, Investigative ophthalmology & visual science.
[26] R. Bodmeier,et al. Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method , 1988 .
[27] G. Holland,et al. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. , 1991, Ophthalmology (Rochester, Minn.).
[28] D. Lewis,et al. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. , 1983, Biology of reproduction.
[29] Y. Ikada,et al. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. , 1992, Investigative ophthalmology & visual science.
[30] Robert Gurny,et al. Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .
[31] A. Bill,et al. Drainage of microspheres and RBCs from the vitreous of aphakic and phakic eyes. , 1979, Archives of ophthalmology.
[32] B. Tighe,et al. Polymers for biodegradable medical devices. VIII. Hydroxybutyrate-hydroxyvalerate copolymers: physical and degradative properties of blends with polycaprolactone. , 1992, Biomaterials.
[33] J M Brady,et al. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.
[34] J. Mcginity,et al. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. , 1992, Journal of microencapsulation.
[35] Y. Ikada,et al. In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release. , 1994, Current eye research.
[36] R. Herrero-Vanrell,et al. Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In-vitro release profile. , 1999, Journal of microencapsulation.
[37] A. Mitra,et al. Kinetics of a Model Nucleoside (Guanosine) Release from Biodegradable Poly(dl-lactide-co-glycolide) Microspheres: A Delivery System for Long-Term Intraocular Delivery , 2000, Pharmaceutical development and technology.
[38] M. Refojo,et al. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. , 1993, Investigative ophthalmology & visual science.
[39] H. Balfour,et al. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. , 1987, American journal of ophthalmology.
[40] A. Delgado,et al. Degradation of DL-PLA-methadone microspheres during in vitro release , 1996 .
[41] Y. Ikada,et al. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits. , 1997, Current eye research.
[42] M. R. Aberturas,et al. Optimized preparation of poly d,l (lactic-glycolic) microspheres and nanoparticles for oral administration , 1996 .
[43] J. Pastor,et al. Proliferative vitreoretinopathy: an overview. , 1998, Survey of ophthalmology.
[44] H. Okada,et al. Biodegradable microspheres in drug delivery. , 1995, Critical reviews in therapeutic drug carrier systems.
[45] A. Joshi. Microparticulates for ophthalmic drug delivery. , 1994, Journal of ocular pharmacology.
[46] M. Vert,et al. The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles: in vivo investigation. , 2000, Journal of microencapsulation.
[47] M. Refojo,et al. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. , 1997, Investigative ophthalmology & visual science.
[48] A. Mitra,et al. Ophthalmic Drug Delivery Systems , 2003 .
[49] R. Cuthbertson,et al. Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[50] D. Chang,et al. Phase II results of an intraocular steroid delivery system for cataract surgery. , 1999, Ophthalmology.